Skip to main content


Cystic fibrosis Market Size & Share Analysis Cystic Fibrosis is a life-limiting autosomal recessive genetic disorder that severely damages the lungs and the digestive system. As per the Delveinsight, the total prevalent population of Cystic Fibrosis in 6MM was 61,306 in 2017. The prevalent population of Cystic Fibrosis in the UK was 10,468, while the US and Spain had a prevalent population of 30,139 and 2,075 respectively in 2017. The Cystic Fibrosis market Size in the 6MM was found to be USD 1,940.1 million in 2017. Some of the key companies in the Cystic Fibrosis market include Translate Bio, Proteostasis Therapeutics, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, ProQR Therapeutics, Ionis Pharmaceuticals, Verona Pharmaceuticals, Eloxx Pharmaceuticals, and many others.